SCHEMBL3801077

SCHEMBL3801077

CN1CCCC1(C)CCN

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6658044 0.84
SCHEMBL5585735 0.76
SCHEMBL15426524 0.76
SCHEMBL5585336 0.76 KDM4E (0.31) SLC6A4
SCHEMBL14992504 0.76
SCHEMBL25349071 0.74
SCHEMBL24718527 0.74
SCHEMBL13448668 0.74
SCHEMBL22007924 0.74 LMNA (0.30)
SCHEMBL12547112 0.74 CYP4F2 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2167093-A1 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHRONIC HEART FAILURE COMPRISING PYRAZOLOPYRIMIDINONE DERIVATIVE COMPOUND Dong-A Pharmaceutical Co., Ltd. (KR) 2010-03-31 EP disclosed
WO-2008153282-A1 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHRONIC HEART FAILURE COMPRISING PYRAZOLOPYRIMIDINONE DERIVATIVE COMPOUND DONG-A PHARMACEUTICAL. CO., LTD (KR) 2008-12-18 WO disclosed